Compare BSL & SWKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | BSL | SWKH |
|---|---|---|
| Founded | 2010 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Diversified Financial Services |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.1M | 205.9M |
| IPO Year | N/A | N/A |
| Metric | BSL | SWKH |
|---|---|---|
| Price | $13.07 | $16.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | ★ 47.6K | 5.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 9.55% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $52.93 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $9.18 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.12 | $13.00 |
| 52 Week High | $14.35 | $18.66 |
| Indicator | BSL | SWKH |
|---|---|---|
| Relative Strength Index (RSI) | 22.05 | 31.64 |
| Support Level | N/A | $16.15 |
| Resistance Level | $13.70 | $17.08 |
| Average True Range (ATR) | 0.06 | 0.24 |
| MACD | -0.01 | -0.08 |
| Stochastic Oscillator | 0.00 | 9.38 |
Blackstone Senior Floating Rate Term Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek high current income, with a secondary objective to seek preservation of capital, consistent with its primary goal of high current income. It also invests in second-lien loans and high yield bonds and employs financial leverage which may increase the risk to the Fund.
SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.